Skip to content
Solved
SearchBrowse
Sign in

Contents

Official guidance
Corporate Intangibles Research and Development Manual

CIRD75000 · VRR

  • CIRD75050 · Introduction
  • CIRD75100 · Vaccine Research Relief: Requirement that Company is a going concern
  • CIRD75200 · Qualifying expenditure: for an accounting period
  • CIRD75300 · Qualifying expenditure: on direct R&D
  • CIRD75400 · Qualifying expenditure: on sub-contracted R&D
  • CIRD75500 · Qualifying expenditure: on contributions to independent R&D
  • CIRD75525 · Subcontracting to charities, universities and scientific research organisations
  • CIRD75550 · Subcontracting to companies and others
  • CIRD75600 · How relief is given: SMEs
  • CIRD75700 · How relief is given: large companies
  • CIRD75800 · How relief is given: insurance companies
  • CIRD75900 · Inflated claims
  • CIRD75950 · Refunds of contributions and subcontract payments
  • CIRD76000 · Specified diseases: general
  • CIRD76100 · Specified diseases: tuberculosis and malaria
  • CIRD76200 · Specified diseases: HIV/AIDS
  • CIRD76300 · Definitions
  • CIRD76400 · Dealing with claims
  1. VRR: contents
  2. VRR: how relief is given: insurance companies

CIRD75800 | VRR: how relief is given: insurance companies

From HM Revenue & Customs · Corporate Intangibles Research and Development Manual

FA02/SCH13/PARA22 - 23

There are special rules for taxing insurance companies and so there are special rules for VRR for them. They apply where the company’s profits from life assurance business are taxed under Case III, V or VI Schedule D rather than Case I. If the company is taxed Case I Schedule D the normal rules apply.

If a company carrying on life assurance business qualifies as an SME treat it as not being an SME for VRR purposes.

If an insurance company’s profits from life assurance business are calculated on the I minus E basis they are not taxed under Case I Schedule D and you should treat VRR as a management expense.

If there is a category of life assurance business charged under Case VI Schedule D by ICTA88/S436, ICTA88/S439B or ICTA88/S441, give VRR as a deduction in calculating the profits of that category of business.

If the I minus E basis applies do not give a company VRR in any Case I computations that it makes.

This provision mirrors that for the general R&D tax relief.

PreviousNext
PrivacyTerms